New Publication on TIF 2.0 in Therapeutic Advances in Gastroenterology Provides a Roadmap as Surgeons and Gastroenterologists Partner to Use the Procedure to Achieve Optimal Outcomes for Patients with Gastroesophageal Reflux Disease (GERD) »
June 17, 2020
Continued evolution of EndoGastric Solutions’ EsophyX technology and concomitant use of TIF 2.0 with hiatal hernia repair brings long-term GERD relief to a broader spectrum of patients REDMOND, Wash – June 17, 2020 – EndoGastric Solutions® today announced the publication of a new review article in Therapeutic Advances in Gastroenterology1 that describes the refinement of […] More »
EndoGastric Solutions Announces New Data Confirming the Efficacy of Concomitant Hiatal Hernia Repair and TIF 2.0 Procedure in Providing Symptom Control for GERD Patients »
September 5, 2019
A 99-patient study confirms that a laparo-endoluminal approach reduces proton pump inhibitor medication use and significantly improves quality-of-life scores REDMOND, Wash – EndoGastric Solutions® today announced the publication of new clinical data confirming that concomitantly performed hiatal hernia (HH) repair and the Transoral Incisionless Fundoplication (TIF® 2.0) procedure using the EsophyX® device, is an effective […] More »
DDW 2019 report on TIF procedure data presented »
June 20, 2019
EndoGastric Solutions Takes the Stage at DDW, World’s Largest Gathering of GI, Hepatology, and Endoscopy Specialists Adrian Lobontiu, MD, FACS, Chief Medical Officer of EndoGastric Solutions Each year, leading researchers and clinicians in the fields of gastroenterology, hepatology, and endoscopy gather at Digestive Disease Week® (DDW®) to share cutting-edge data and gain insights into the […] More »
- 1
- 2
- 3
- …
- 16
- Next Page »